CLASS II ONGOING Device recall · Reported 5 Mar 2025 · FDA Enforcement Report

IntelePACS (Image Fusion Module) - InteleViewer recalled

Intelerad Medical Systems is recalling IntelePACS (Image Fusion Module) - InteleViewer, distributed nationwide in the US. The recall was initiated on 5 Feb 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: B228INTELEPACS0, Device Versions: 5-6-1-P23 and later
Quantity recalled88

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1208-2025
FDA event ID
96270
Recalling firm
Intelerad Medical Systems, Montreal, N/A
Classification
Class II
Status
Ongoing
Recall initiated
5 Feb 2025
FDA classified
21 Feb 2025
Reported
5 Mar 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

5 Feb 2025Recall initiated by company
21 Feb 2025Classified by FDA+16 days
5 Mar 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A software application that receives digital images and data from various sources has a bug in specific software versions that will calculate the Standard Uptake Value (SUV) incorrectly for PET/CT studies acquired on the days of Daylight Savings Time (DST); only on dates in which DST transition occurs; all other dates are unaffected. An incorrect SUV may lead to an incorrect diagnosis.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

IntelePACS (Image Fusion Module) - InteleViewer

Where it was distributed

Worldwide - US Nationwide distribution in the states of AZ, NC, MI, FL, NH, WY, CA, SC, AL, AR, IN, MD, CO, TN, IL, NJ, OH, MN, WV, KE, NE, VA, WA, GE, WI and the countries of New Zealand, Canada, Australia

Nationwide AlabamaArkansasArizonaCaliforniaColoradoFloridaIllinoisIndianaMarylandMichiganMinnesotaNorth CarolinaNebraskaNew HampshireNew JerseyOhioSouth CarolinaTennesseeVirginiaWashington

Questions about this recall

Why was it recalled?

A software application that receives digital images and data from various sources has a bug in specific software versions that will calculate the Standard Uptake Value (SUV) incorrectly for PET/CT studies acquired on the days of Daylight Savings Time (DST); only on dates in which DST transition occurs; all other dates are unaffected. An incorrect SUV may lead to an incorrect diagnosis.

Which lots are affected?

UDI-DI: B228INTELEPACS0, Device Versions: 5-6-1-P23 and later

Where was it sold?

Worldwide - US Nationwide distribution in the states of AZ, NC, MI, FL, NH, WY, CA, SC, AL, AR, IN, MD, CO, TN, IL, NJ, OH, MN, WV, KE, NE, VA, WA, GE, WI and the countries of New Zealand, Canada, Australia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Intelerad Medical Systems

All 3

Other Other Medical Devices recalls

All 13,908